[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

March 2024 | 111 pages | ID: G86CA92153C7EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Neuromyelitis optica (NMO), also known as Devic's disease, is a rare condition where the immune system damages the spinal cord and the nerves of the eyes (optic nerves).NMO can affect anyone at any age, but it's more common in women than men.

The Global Info Research report includes an overview of the development of the Neuromyelitis Optica Spectrum Disorders (NMOSD) industry chain, the market status of Hospital (Relapsing Form, Monophasic Form), Clinic (Relapsing Form, Monophasic Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neuromyelitis Optica Spectrum Disorders (NMOSD).

Regionally, the report analyzes the Neuromyelitis Optica Spectrum Disorders (NMOSD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Neuromyelitis Optica Spectrum Disorders (NMOSD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neuromyelitis Optica Spectrum Disorders (NMOSD) industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Relapsing Form, Monophasic Form).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neuromyelitis Optica Spectrum Disorders (NMOSD) market.

Regional Analysis: The report involves examining the Neuromyelitis Optica Spectrum Disorders (NMOSD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neuromyelitis Optica Spectrum Disorders (NMOSD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Neuromyelitis Optica Spectrum Disorders (NMOSD):

Company Analysis: Report covers individual Neuromyelitis Optica Spectrum Disorders (NMOSD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neuromyelitis Optica Spectrum Disorders (NMOSD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Neuromyelitis Optica Spectrum Disorders (NMOSD). It assesses the current state, advancements, and potential future developments in Neuromyelitis Optica Spectrum Disorders (NMOSD) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neuromyelitis Optica Spectrum Disorders (NMOSD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Neuromyelitis Optica Spectrum Disorders (NMOSD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
  • Relapsing Form
  • Monophasic Form
Market segment by Application
  • Hospital
  • Clinic
Market segment by players, this report covers
  • Roche
  • Pfizer
  • Fresenius
  • Teva
  • Sandoz
  • Intas
  • Nang Kuang Pharmaceutical
  • Tianjin King York
  • Baxter
  • CSL
  • Grifols
  • Octapharma
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Neuromyelitis Optica Spectrum Disorders (NMOSD) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Neuromyelitis Optica Spectrum Disorders (NMOSD), with revenue, gross margin and global market share of Neuromyelitis Optica Spectrum Disorders (NMOSD) from 2019 to 2024.

Chapter 3, the Neuromyelitis Optica Spectrum Disorders (NMOSD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neuromyelitis Optica Spectrum Disorders (NMOSD) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Neuromyelitis Optica Spectrum Disorders (NMOSD).

Chapter 13, to describe Neuromyelitis Optica Spectrum Disorders (NMOSD) research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Neuromyelitis Optica Spectrum Disorders (NMOSD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neuromyelitis Optica Spectrum Disorders (NMOSD) by Type
  1.3.1 Overview: Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type in 2023
  1.3.3 Relapsing Form
  1.3.4 Monophasic Form
1.4 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market by Application
  1.4.1 Overview: Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospital
  1.4.3 Clinic
1.5 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size & Forecast
1.6 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast by Region
  1.6.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region: 2019 VS 2023 VS 2030
  1.6.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region, (2019-2030)
  1.6.3 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Prospect (2019-2030)
  1.6.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Prospect (2019-2030)
  1.6.5 Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Prospect (2019-2030)
  1.6.6 South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Prospect (2019-2030)
  1.6.7 Middle East and Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Prospect (2019-2030)

2 COMPANY PROFILES

2.1 Roche
  2.1.1 Roche Details
  2.1.2 Roche Major Business
  2.1.3 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.1.4 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Roche Recent Developments and Future Plans
2.2 Pfizer
  2.2.1 Pfizer Details
  2.2.2 Pfizer Major Business
  2.2.3 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.2.4 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Pfizer Recent Developments and Future Plans
2.3 Fresenius
  2.3.1 Fresenius Details
  2.3.2 Fresenius Major Business
  2.3.3 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.3.4 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Fresenius Recent Developments and Future Plans
2.4 Teva
  2.4.1 Teva Details
  2.4.2 Teva Major Business
  2.4.3 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.4.4 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Teva Recent Developments and Future Plans
2.5 Sandoz
  2.5.1 Sandoz Details
  2.5.2 Sandoz Major Business
  2.5.3 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.5.4 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Sandoz Recent Developments and Future Plans
2.6 Intas
  2.6.1 Intas Details
  2.6.2 Intas Major Business
  2.6.3 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.6.4 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Intas Recent Developments and Future Plans
2.7 Nang Kuang Pharmaceutical
  2.7.1 Nang Kuang Pharmaceutical Details
  2.7.2 Nang Kuang Pharmaceutical Major Business
  2.7.3 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.7.4 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Nang Kuang Pharmaceutical Recent Developments and Future Plans
2.8 Tianjin King York
  2.8.1 Tianjin King York Details
  2.8.2 Tianjin King York Major Business
  2.8.3 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.8.4 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Tianjin King York Recent Developments and Future Plans
2.9 Baxter
  2.9.1 Baxter Details
  2.9.2 Baxter Major Business
  2.9.3 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.9.4 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Baxter Recent Developments and Future Plans
2.10 CSL
  2.10.1 CSL Details
  2.10.2 CSL Major Business
  2.10.3 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.10.4 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 CSL Recent Developments and Future Plans
2.11 Grifols
  2.11.1 Grifols Details
  2.11.2 Grifols Major Business
  2.11.3 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.11.4 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 Grifols Recent Developments and Future Plans
2.12 Octapharma
  2.12.1 Octapharma Details
  2.12.2 Octapharma Major Business
  2.12.3 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
  2.12.4 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Octapharma Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
  3.2.1 Market Share of Neuromyelitis Optica Spectrum Disorders (NMOSD) by Company Revenue
  3.2.2 Top 3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Players Market Share in 2023
  3.2.3 Top 6 Neuromyelitis Optica Spectrum Disorders (NMOSD) Players Market Share in 2023
3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Overall Company Footprint Analysis
  3.3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Region Footprint
  3.3.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Type Footprint
  3.3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Forecast by Type (2025-2030)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application (2019-2024)
5.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Forecast by Application (2025-2030)

6 NORTH AMERICA

6.1 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2030)
6.2 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2030)
6.3 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
  6.3.1 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2030)
  6.3.2 United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  6.3.3 Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  6.3.4 Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)

7 EUROPE

7.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2030)
7.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2030)
7.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
  7.3.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2030)
  7.3.2 Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  7.3.3 France Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  7.3.4 United Kingdom Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  7.3.5 Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  7.3.6 Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)

8 ASIA-PACIFIC

8.1 Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region
  8.3.1 Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2030)
  8.3.2 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  8.3.3 Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  8.3.4 South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  8.3.5 India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  8.3.6 Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  8.3.7 Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)

9 SOUTH AMERICA

9.1 South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2030)
9.2 South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2030)
9.3 South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
  9.3.1 South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2030)
  9.3.2 Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  9.3.3 Argentina Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
  10.3.1 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2030)
  10.3.2 Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  10.3.3 Saudi Arabia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)
  10.3.4 UAE Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size and Forecast (2019-2030)

11 MARKET DYNAMICS

11.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
11.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Restraints
11.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Chain
12.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Upstream Analysis
12.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Midstream Analysis
12.4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 8. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 13. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Fresenius Company Information, Head Office, and Major Competitors
Table 16. Fresenius Major Business
Table 17. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 18. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Fresenius Recent Developments and Future Plans
Table 20. Teva Company Information, Head Office, and Major Competitors
Table 21. Teva Major Business
Table 22. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 23. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Teva Recent Developments and Future Plans
Table 25. Sandoz Company Information, Head Office, and Major Competitors
Table 26. Sandoz Major Business
Table 27. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 28. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sandoz Recent Developments and Future Plans
Table 30. Intas Company Information, Head Office, and Major Competitors
Table 31. Intas Major Business
Table 32. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 33. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Intas Recent Developments and Future Plans
Table 35. Nang Kuang Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Nang Kuang Pharmaceutical Major Business
Table 37. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 38. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Nang Kuang Pharmaceutical Recent Developments and Future Plans
Table 40. Tianjin King York Company Information, Head Office, and Major Competitors
Table 41. Tianjin King York Major Business
Table 42. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 43. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Tianjin King York Recent Developments and Future Plans
Table 45. Baxter Company Information, Head Office, and Major Competitors
Table 46. Baxter Major Business
Table 47. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 48. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Baxter Recent Developments and Future Plans
Table 50. CSL Company Information, Head Office, and Major Competitors
Table 51. CSL Major Business
Table 52. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 53. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. CSL Recent Developments and Future Plans
Table 55. Grifols Company Information, Head Office, and Major Competitors
Table 56. Grifols Major Business
Table 57. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 58. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Grifols Recent Developments and Future Plans
Table 60. Octapharma Company Information, Head Office, and Major Competitors
Table 61. Octapharma Major Business
Table 62. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Solutions
Table 63. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Octapharma Recent Developments and Future Plans
Table 65. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (USD Million) by Players (2019-2024)
Table 66. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Share by Players (2019-2024)
Table 67. Breakdown of Neuromyelitis Optica Spectrum Disorders (NMOSD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Neuromyelitis Optica Spectrum Disorders (NMOSD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Neuromyelitis Optica Spectrum Disorders (NMOSD) Players
Table 70. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Type Footprint
Table 71. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Application Footprint
Table 72. Neuromyelitis Optica Spectrum Disorders (NMOSD) New Market Entrants and Barriers to Market Entry
Table 73. Neuromyelitis Optica Spectrum Disorders (NMOSD) Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Share by Type (2019-2024)
Table 76. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Forecast by Type (2025-2030)
Table 77. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2024)
Table 78. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Forecast by Application (2025-2030)
Table 79. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Neuromyelitis Optica Spectrum Disorders (NMOSD) Raw Material
Table 110. Key Suppliers of Neuromyelitis Optica Spectrum Disorders (NMOSD) Raw Materials

LIST OF FIGURE
s
Figure 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Picture
Figure 2. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type in 2023
Figure 4. Relapsing Form
Figure 5. Monophasic Form
Figure 6. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Region in 2023
Figure 15. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Share by Players in 2023
Figure 21. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share in 2023
Figure 23. Global Top 6 Players Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share in 2023
Figure 24. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Share by Type (2019-2024)
Figure 25. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share Forecast by Type (2025-2030)
Figure 26. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Share by Application (2019-2024)
Figure 27. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share Forecast by Application (2025-2030)
Figure 28. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 38. France Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Region (2019-2030)
Figure 45. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 48. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 62. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
Figure 63. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Restraints
Figure 64. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2023
Figure 67. Manufacturing Process Analysis of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Figure 68. Neuromyelitis Optica Spectrum Disorders (NMOSD) Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source


More Publications